Imatinib and Xanax (Alprazolam) (Xanax 0.5 mg): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Imatinib may inhibit CYP3A-mediated alprazolam metabolism and increase sedative exposure.
Clinical significance and safety
Xanax 0.5 mg contains alprazolam, a triazolobenzodiazepine metabolized by CYP3A. Imatinib can raise exposure to this class, potentially increasing or prolonging sedation. Review is especially important with other sedating medicines or impaired alertness.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.